Does Zilbrysq Cause Joint Pain? What the Research Says

Zilbrysq is a medication for generalized myasthenia gravis, and some patients do report joint pain while taking it. However, joint pain is not listed as a common side effect in the official prescribing information from the FDA. This article breaks down what the research actually says about Zilbrysq and joint pain, so you can separate fact from fear.

What Is Zilbrysq and How Does It Work?

Zilbrysq (zilucoplan) is a once-daily injectable treatment for generalized myasthenia gravis (gMG) in adults who test positive for acetylcholine receptor antibodies. It belongs to a class of drugs called complement inhibitors. These drugs block part of your immune system called the complement cascade, which can damage the connection between nerves and muscles in MG.

The FDA approved Zilbrysq in October 2023 based on results from a phase 3 clinical trial. That trial, published in The Lancet Neurology, showed that Zilbrysq significantly improved muscle strength and daily function compared to placebo. The drug works differently from other MG treatments like steroids or IVIG. It targets a specific immune pathway rather than broadly suppressing the immune system.

Because Zilbrysq is still relatively new, real-world data on its side effects is still growing. Most of what doctors know comes from the clinical trial and early patient reports. This matters when evaluating whether the drug truly causes joint pain.

Does Zilbrysq Cause Joint Pain? What Clinical Trials Show

The phase 3 RAISE trial included 166 patients with gMG. Researchers tracked all side effects reported during the 12-week study. Joint pain, medically called arthralgia, was reported by about 3% of patients taking Zilbrysq. That same percentage of patients in the placebo group also reported joint pain. Statistically, this means the rate was the same in both groups.

A 3% rate in both arms suggests that joint pain during the trial was likely not caused by Zilbrysq. It may have been related to myasthenia gravis itself, other medications patients were taking, or simply chance. The prescribing information for Zilbrysq does not list joint pain as a known side effect. The most common side effects reported were injection site reactions, upper respiratory infections, and diarrhea.

Some patients in online forums do report joint pain while on Zilbrysq. These personal accounts are real and deserve attention. However, they do not replace controlled clinical data. Without a larger group of patients not taking the drug for comparison, it is impossible to know if Zilbrysq caused their pain or if something else did.

Why Some People Might Experience Joint Pain on Zilbrysq

Even if clinical trials do not show a clear link, individual experiences vary. There are a few reasons someone on Zilbrysq might develop joint pain that have nothing to do with the drug itself.

First, myasthenia gravis can cause muscle weakness that changes how you walk, sit, or stand. Over time, poor posture or altered movement patterns can stress your joints. This can lead to pain in the knees, hips, or back. The pain comes from the joint strain, not from the medication.

Second, many people with MG take multiple medications. Prednisone, for example, is a common treatment for MG and is well known to cause joint problems over time, including osteoporosis and avascular necrosis. If you are on prednisone and Zilbrysq together, joint pain is more likely from the steroid.

Third, the stress of living with a chronic illness can make you more sensitive to pain. Research in journals like Pain has shown that chronic stress and depression lower your pain threshold. If you start a new drug and feel anxious about side effects, you may notice aches you would otherwise ignore.

How Zilbrysq Compares to Other MG Treatments for Joint Pain

To understand whether Zilbrysq is risky for joints, it helps to compare it to other MG drugs.

As the table shows, Zilbrysq has a much lower signal for joint pain than long-term steroid use. If you are switching from prednisone to Zilbrysq, any joint pain you have may actually improve over time as you lower your steroid dose.

What to Do If You Have Joint Pain While Taking Zilbrysq

If you start Zilbrysq and develop joint pain, do not stop the medication without talking to your neurologist first. Stopping a complement inhibitor suddenly can cause your MG symptoms to return quickly. Instead, take these steps.

Keep a symptom diary. Write down when the pain started, where it is, how bad it is on a 1-10 scale, and what makes it better or worse. Note any other changes like new medications, activity levels, or diet. This information helps your doctor identify the real cause.

Check your other medications. Review everything you take, including over-the-counter drugs and supplements. Some NSAIDs like ibuprofen can interact with Zilbrysq. Your doctor needs to know your full list.

Ask for a physical therapy evaluation. A physical therapist can assess whether your joint pain is from muscle weakness and poor body mechanics rather than the drug. They can give you exercises to strengthen supporting muscles and improve your posture.

Consider a short trial of acetaminophen (Tylenol) for pain relief. Acetaminophen is generally safe with Zilbrysq. Avoid NSAIDs unless your doctor approves them first, because they can affect kidney function, and Zilbrysq carries a small risk of kidney issues.

What the Research Does and Does Not Tell Us

The clinical research on Zilbrysq is clear: joint pain was not more common in people taking the drug than in those taking a placebo. The FDA reviewed this data and did not include joint pain as a warning or precaution in the labeling.

However, clinical trials have limits. They are relatively short, usually 12 to 24 weeks. Long-term side effects can take months or years to appear. The RAISE trial also excluded people with certain other health conditions, so the results may not apply to everyone. Real-world use often reveals side effects that trials miss.

As of 2026, there are no published studies specifically investigating whether Zilbrysq causes joint pain. The evidence we have is from the trial data and post-marketing reports. The FDA continues to monitor side effects through its Adverse Event Reporting System (FAERS). So far, no signal for joint pain has emerged.

If you experience joint pain that is severe, persistent, or getting worse, report it to your doctor and to the FDA through the MedWatch program. Your report helps build a clearer picture of the drug’s real-world effects.

Common Misconceptions About Zilbrysq and Joint Pain

One common myth is that Zilbrysq causes autoimmune arthritis. There is no evidence for this. Zilbrysq suppresses one part of the immune system, but it does not trigger new autoimmune diseases in the joints.

Another misconception is that injection site reactions near a joint mean the drug is damaging that joint. Injection site reactions like redness, swelling, or tenderness happen under the skin, not inside the joint. They are uncomfortable but not harmful to the joint itself.

Some people also believe that because Zilbrysq is a biologic drug, it must cause joint pain like other biologics do. This is not accurate. Different biologic drugs target different pathways. For example, TNF inhibitors used for rheumatoid arthritis can cause joint pain in some people, but Zilbrysq targets a completely different immune molecule called complement protein C5. The side effect profile is not the same.